4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-023939
President and CEO sold 707 shares at $9.15 ($6,469)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AHMED NADIM President and CEO | 2023-05-23 | Sale | −707 | $9.15 | $6,469 | 116,581 | D: show line 1 in the form |
| Open-market sales · 707 sh · avg $9.15 · $6,469 | |||||||
Loading xslF345X04/ownership.xml…